For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...

This is Nigeria’s development trap. By externalising health and environmental costs, the system creates the illusion of affordability while steadily eroding human capital. Productivity gains achieved ...

Cervical Cancer Awareness Month 2026 highlights how HPV vaccination and regular screening can prevent cervical cancer, reduce ...

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...

A recent study published in the medical journal Gut has revealed a novel cancer-promoting mechanism of Streptococcus ...

AbbVie said on Monday it would partner with Chinese drug developer RemeGen for an experimental treatment targeting solid ...

The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...

Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...

NP-G2-044 (Prilukae), a novel oral fascin inhibitor, has earned orphan drug designation (ODD) from the FDA for the treatment ...

The collaborative clinical study will evaluate ADSTILADRIN® (nadofaragene firadenovec-vncg) in combination with the investigational drug Ruvidar® (TLD-1433) in patients with Bacillus ...

Global cancer cases have surged dramatically, doubling since 1990 and reaching 18.5 million new diagnoses in 2023. Deaths ...